Cannabinoid Encyclopedia Clear answers. Trusted sources.

Focused research review

Does CBG help with anxiety?

CBG has been studied in one small placebo-controlled human field trial, alongside animal stress, fear, and anxiety-behavior studies. That is not enough to establish that CBG treats anxiety.

Updated July 2026 7 research sources Human and early research

The short answer

What is the bottom line?

Current CBG anxiety evidence is preliminary and does not establish a treatment effect. 1 2 3 4

The human and animal studies ask different questions in different settings. A short field-trial result, a rat anxiety model, or a fear-memory experiment cannot be combined into one general conclusion about anxiety in people. 1 2 3 4

What this means: Use this page to separate the small human study from animal and mechanism research. The key questions are the exact product, dose, setting, outcome, comparison group, and whether a result was reproduced. 1 2 3 4

How to read this answer: Use this page to separate the small human study from animal and mechanism research. The key questions are the exact product, dose, setting, outcome, comparison group, and whether a result was reproduced. 1

Key takeaways

What to know first

  1. 1

    The approved CBG anxiety set includes one preliminary human field trial and several animal or mechanism studies. 1

  2. 2

    Animal stress, fear-memory, and anxiety-behavior experiments do not establish a human anxiety treatment result. 2

  3. 3

    CBG-alone exposure, study setting, dose, outcome, and comparator must stay visible when interpreting the evidence. 3

Choose your question

What do you want to know about CBG and anxiety?

Start by separating acute human findings, animal behavior models, and mechanism research. They answer different questions.

  1. 01Reader question

    What human evidence exists?

    Read the preliminary field-trial context without generalizing it to every anxiety question.

    Explore the evidence
  2. 02Reader question

    What do animal studies show?

    Explore stress, fear, and anxiety-behavior models as preclinical context.

    Explore the evidence
  3. 03Reader question

    What would stronger evidence look like?

    Look for a defined population, CBG product, dose, comparator, outcome, and follow-up.

    Explore the evidence

Research areas

What researchers studied about CBG and anxiety

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly preclinical

Anxiety-related outcomes

This part of the literature focuses on Anxiety-related outcomes. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

1 source

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

1 source

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

5 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on CBG and anxiety is not one kind of study. This source set includes 5 animal studies, 1 clinical study in people, and 1 narrative or expert review. 3

The recorded populations or models include animal models (5 sources) and people or patients (1 source). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is anxiety-related or neurobehavioral outcomes (7 sources). Closely related outcome names can still describe different measurements. 5

The CBG and anxiety source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

clinical study in people

Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial.

On this page, this source examines CBG and anxiety-related outcomes. 1

Study type
clinical study in people
Population or model
people or patients
Outcome focus
anxiety-related or neurobehavioral outcomes
Evidence stage
human research

animal study

Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain.

On this page, this source examines CBG and anxiety-related outcomes. 2

Study type
animal study
Population or model
animal models
Outcome focus
anxiety-related or neurobehavioral outcomes
Evidence stage
preclinical research

animal study

The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice.

On this page, this source examines CBG and anxiety-related outcomes. 3

Study type
animal study
Population or model
animal models
Outcome focus
anxiety-related or neurobehavioral outcomes
Evidence stage
preclinical research

animal study

Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat.

On this page, this source examines CBG and anxiety-related outcomes. 4

Study type
animal study
Population or model
animal models
Outcome focus
anxiety-related or neurobehavioral outcomes
Evidence stage
mechanism-focused research

narrative or expert review

Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives.

On this page, this source examines CBG and anxiety-related outcomes. 5

Study type
narrative or expert review
Outcome focus
anxiety-related or neurobehavioral outcomes
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on CBG and anxiety should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

Does CBG help anxiety?

The current evidence is preliminary and does not establish that CBG treats anxiety. It includes one small human field trial plus animal and mechanism research. 7

Is a field trial the same as treatment research?

No. A short, controlled field trial can measure an acute outcome in a specific setting, but it cannot establish long-term treatment benefit for an anxiety disorder. 1

Why do mouse fear and rat anxiety studies matter?

They can identify research questions and possible biology, but they cannot predict a human symptom change or safety outcome on their own. 2

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. clinical study in people; human research PubMed 39003387 DOI 10.1038/s41598-024-66879-0
  2. 2
    Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain. animal study; preclinical research PubMed 39322049 DOI 10.1016/j.pbb.2024.173883
  3. 3
    The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice. animal study; preclinical research PubMed 34182770 DOI 10.1089/can.2021.0027
  4. 4
    Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat. animal study; mechanism-focused research PubMed 37305529 DOI 10.3389/fphar.2023.1183019
  5. 5
    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. narrative or expert review; evidence still limited PubMed 36397993 DOI 10.1155/2022/3336516
  6. 6
    Cannabigerol and Cannabinoid Receptors in Major Depressive Disorder: Network Pharmacology, Molecular Docking, and In-vivo Analysis. animal study; mechanism-focused research PubMed 40326034 DOI 10.2174/0115701638363093250324035540
  7. 7
    Cannabigerol does not affect contextual fear memory in mice but modulates nociception in a sex-dependent manner. animal study; preclinical research PubMed 40523564 DOI 10.1016/j.pbb.2025.174053
See all 7 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain. animal study; preclinical research / 1 linked research note PubMed 39322049
  2. Cannabigerol does not affect contextual fear memory in mice but modulates nociception in a sex-dependent manner. animal study; preclinical research / 1 linked research note PubMed 40523564
  3. Cannabigerol and Cannabinoid Receptors in Major Depressive Disorder: Network Pharmacology, Molecular Docking, and In-vivo Analysis. animal study; mechanism-focused research / 1 linked research note PubMed 40326034
  4. Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial. clinical study in people; human research / 1 linked research note PubMed 39003387
  5. Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat. animal study; mechanism-focused research / 1 linked research note PubMed 37305529
  6. Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives. narrative or expert review; evidence still limited / 1 linked research note PubMed 36397993
  7. The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice. animal study; preclinical research / 1 linked research note PubMed 34182770